NCT00392457View on ClinicalTrials.gov

Investigating the Regulation of Reproductive Hormones in Adult Men

NACompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

July 31, 1995

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Kallmann SyndromeHypogonadismGonadal Disorder
Interventions
DRUG

ketoconazole

loading dose of 1g followed by a maintenance dose of 400 mg PO QID for 7 days

DRUG

gonadotropin releasing hormone (GnRH)

Pulsatile GnRH (25 ng/kg per bolus every two hours via microinfusion pump titrated to reach normal serum testosterone levels)

Trial Locations (1)

02114-2696

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00392457 - Investigating the Regulation of Reproductive Hormones in Adult Men | Biotech Hunter | Biotech Hunter